Found 28 results
Author Title [ Type(Desc)] Year
Filters: Author is Wolff, M  [Clear All Filters]
Journal Article
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8+ Cytotoxic T Lymphocyte Responses in Seronegative Volunteers, J Infec Dis, vol. 180, no. 2, pp. 290-298, 1999.
M. Wolff, Moulton, L. H., Newcomer, W., Reid, R., and Santo, S. M., A Case-Control-Study of Risk Factors for Homophiles Influenza Type B Disease in Navajo Children, AM J Trop Med Hug, vol. 60, no. 2, pp. 263-266, 1999.
K. L. Kotloff, Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., Creech, C. B., Healy, S. A., Dolor, R. J., Stephens, I., Edwards, K. M., Noah, D. L., Hill, H., and Wolff, M., Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children, Pediatr Infect Dis J, vol. 33, pp. 865-871, 2014.
R. W. Frenck Jr, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, E. B., Cate, T. R., Edwards, K. M., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults, Vaccine, vol. 29, no. 34, pp. 5666-5674, 2011.
B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine, J Infec Dis, vol. 181, pp. 11133-7, 2000.
R. B. Sack, Santosham, M., Reid, R., Black, R., Croll, J., Yolken, R., Aurelian, L., Wolff, M., Chan, E., Garrett, S., and et, al., Diarrhoeal Diseases in the White Mountain Apaches: Clinical Studies, J Diarrhoeal Dis Res, vol. 13, no. 1, pp. 12-17, 1995.
M. Santosham, Sack, R. B., Reid, R., Black, R., Croll, J., Yolken, R., Aurelian, L., Wolff, M., Chan, E., and Garrett, S., Diarrhoeal Diseases in the White Mountain Apaches: Epidemiologic Studies, Diarrhoeal Dis Res, vol. 13, no. 1, pp. 18-28, 1995.
M. Laassri, Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., and Chumakov, K., Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains, J Infect Dis, vol. 192, pp. 2092-2098, 2005.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults, Vaccine, vol. 20, pp. 1099-1105, 2002.
L. R. Baden, ,, Seaman, M. S., Johnson, J. A., Tucker, R. P., Kleinjan, J. A., Gothing, J. A., Engelson, B. A., Carey, B. R., Oza, A., Bajimaya, S., Peter, L., Bleckwehl, C., Abbink, P., Pau, M. G., Weijtens, M., Kunchai, M., Swann, E. M., Wolff, M., Dolin, R., and Barouch, D. H., First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002), J Infect Dis, vol. 210, pp. 1052-1061, 2014.
L. R. Baden, ,, Seaman, M. S., Tucker, R. P., Krause, K. H., Patel, A., Johnson, J. A., Kleinjan, J., Yanosick, K. E., Perry, J., Zablowsky, E., Abbink, P., Peter, L., Iampietro, M. J., Cheung, A., Pau, M. G., Weijtens, M., Goudsmit, J., Swann, E., Wolff, M., Loblein, H., and Dolin, R., First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001), J Infect Dis, vol. 207, pp. 240-247, 2013.
N. A. Goji, Nolan, C., Hill, H., Wolff, M., Noah, D. L., Williams, T. B., Rowe, T., and Treanor, J. J., Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine After Priming with an Antigenic Variant, J Infec Dis, vol. 198, pp. 635-641, 2008.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., Creech, C. B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. R., Wolff, M., and Edwards, K. M., Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women, J Infect Dis, vol. 204, pp. 854-863, 2011.
S. T. Callahan, Wolff, M., Hill, H. R., and Edwards, K. M., Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults, J Infect Dis, vol. 210, no. 8, pp. 1270-1274, 2014.
L. Baden, Liu, J., Li, H., Johnson, J., Walsh, S., Kleinjan, J., Engelson, B., Peter, L., Abbink, P., ,, Golden, K., Viani, K., Stachler, M., Chen, B., ,, Wolff, M., Loblein, H., Seaman, M., Dolin, R., and Barouch, D., Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans, J Infect Dis, vol. 211, pp. 518-528, 2015.
P. B. Gilbert, Chiu, Y. L., Allen, M., Lawrence, D. N., Chapdu, C., Israel, H., Holman, D., Keefer, M. C., Wolff, M., Frey, S. E., and Network, N. I. A. I. D. H. I. V. Vaccin, Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials, Vaccine, vol. 21-22, pp. 2933-2947, 2003.
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., Kotloff, K. L., Chua, J. V., Hutter, J., Stephens, I., Stapleton, J., Meier, J., Callahan, S. T., Creech, C. B., Halasa, N. B., Johnston, C., Dolor, R. J., Schmader, K. E., Woods, C. W., and Hill, H., Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009, Vaccine, vol. 13, pp. 4240-4248, 2012.
M. J. McElrath, Corey, L., Montefiori, D., Wolff, M., Schwartz, D., Keefer, M., Belshe, R., Graham, B. S., Matthews, T., Wright, P., Gorse, G., Dolin, R., Berman, P., Francis, D., Duliege, A. M., Bolognesi, D., Stablein, D., Ketter, N., and Fast, P., A Phase II Study of Two HIV-1 Envelope Vaccines Comparing their Immunogenicity in Populations at Risk for Acquiring HIV-1 Infection, AIDS Res HumRetroviruses, vol. 16, pp. 907-19, 2000.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, Vaccine, vol. 33, pp. 163-173, 2015.
E. Hook, Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Seña, A., Martin, D., Langley, C., McNeil, L., and Wolff, M., A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for Treatment of Early Syphilis, J Infect Dis, vol. 201, pp. 1729-1735, 2010.
A. C. Seña, Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P. A., Langley, C., McNeil, L., and Hook, E. W., Predictors of Serological Cure and Serofast State After Treatment in HIV-Negative Persons With Early Syphilis, Clin Infect Dis, vol. 11, pp. 1092-1099, 2011.
K. M. Holman, Wolff, M., Seña, A. C., Martin, D. H., Behets, F., Van Damme, K., Leone, P. A., McNeil, L., Gehrig, M. L., and Hook, E. W. 3rd, Rapid Plasma Reagin Titer Variation in the 2 Weeks After Syphilis Therapy, Sex Transm Dis, vol. 39, pp. 645-647, 2012.
A. C. Seña, Wolff, M., Behets, F., Van Damme, K., Martin, D. H., Leone, P., McNeil, L., and Hook, E. W., Response to Therapy Following Retreatment of Serofast Early Syphilis Patients with Benzathine Penicillin, Clin Infect Dis, vol. 56, no. 3, pp. 420-422, 2013.
B. Rivoire, Groathouse, N., TerLouw, S., K Neupane, D., Ranjit, C., B Sapkota, R., Khadge, S., Kunwar, C., Macdonald, M., Hawksworth, R., Thapa, M., Hagge, D., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., ,, Sizemore, C., and Brennan, P., Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study, PLOS Neglected Tropical Diseases, vol. 8, p. e2811, 2014.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations, J Infect Dis, vol. 206, pp. 828-837, 2012.